Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 500 participants.
Also called NCT02024230
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 500 participants
- Sponsor
- Fujita Health University
- Registry
-
NCT02024230
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02024230. Non-randomized; no masking; primary purpose treatment. Start 2014-01 (actual); primary completion 2018-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)
- Acronym
- REWRAPS
- Condition
- Coronary Artery Disease
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Condition
- Fetal Blood Loss
- Condition
- Major Bleeding
- Condition
- All Cause Mortality
- Intervention (Drug)
- Rivaroxaban or Warfarin
- Lead sponsor
- Fujita Health University
Record details
- Record id
cardio:ct-nct02024230- Content hash
5720972bc5af9d0ee7eea4411d2b26e1e6b81138a8c083f6f4c17f81e50f0cff